Clinical Studies Search

Protocol Summary


Protocol No.
PSCI-18-102
Prinicipal Investigator
Neves, Rogerio
Phase
NA
Age Group
Adult
Scope
National
Secondary Protocol No.
CBI 2018 SLNBretro 001
Title
DecisionDx-Melanoma Gene Expression Profile Test Result to Predict Riskof Sentinel Lymph Node (SLN) Metastasis
Objective
Primary Aim 1. Determine frequency of positive SLN by GEP subclass
Primary Aim 2: Confirm whether gene expression profiling (GEP) with the 31-GEP signature (DecisionDxMelanoma) can predict risk of SLN metastasis in patients who are ≥55 years old and have tumors with T1-
T2 Breslow thickness
Primary Aim 3: Combine these results with those of a previously evaluated cohort to improve confidence intervals of SLN metastasis risk prediction
Applicable Disease Sites
Other
Status
Open
Participating Institutions
Hershey Medical Center